Literature DB >> 24843094

What predicts outcome after recanalization of chronic venous obstruction: hemodynamic factors, stent geometry, patient selection, anticoagulation or other factors?

H Jalaie1, Cwkp Arnoldussen2, Me Barbati3, Rlm Kurstjens4, R de Graaf5, J Grommes3, A Greiner3, Ma de Wolf4, Cha Wittens6.   

Abstract

In this review we evaluated the effect of different suggested factors associate with the outcome after recanalization of chronic venous obstruction (CVO). HEMODYNAMIC FACTORS: Based upon literature no clear suggestions can be made to identify the risk of stent occlusion in association with the hemodynamic effects. However it is evident that ensuring optimal in- and outflow of the stented tract is key in maintaining the patency. PATIENT SELECTION: Noninvasive imaging modalities are used to divide patients in three subgroups based on the place and extension of post-thrombotic changes. Moreover it should be noted that AV fistula in selected patients can reduce the risk of thrombosis or re-occlusion. GEOMETRY: Excessive oversizing of the stent and stent compression from outside are considered to be associated with stent occlusion. Additionally, overlapping rigid stents, unnatural angel between stents and in-stent kinking are other geometrical factors related to worse outcome after venous recanalization. ANTICOAGULATION: Adequate peri-and postoperative anticoagulation has a crutial role in stent patency. There is no data regarding the duration of anticoagulation therapy and recommendations vary between 6 weeks to 6 months. RESULT: impaired inflow or outflow, presence of a hypercoagulability, total number of treated segments and use of stents designed for implantation in arterial system are associated with decreased stent patency.
© The Author(s) 2014 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav.

Entities:  

Keywords:  Venous recanalization; chronic venous obstruction; endophlebectomy; outcome after venous recanalization; post-thrombotic syndrome

Year:  2014        PMID: 24843094     DOI: 10.1177/0268355514529510

Source DB:  PubMed          Journal:  Phlebology        ISSN: 0268-3555            Impact factor:   1.740


  5 in total

Review 1.  The Treatment of Post-Thrombotic Syndrome.

Authors:  Karina Schleimer; Mohammad Esmaeil Barbati; Alexander Gombert; Volker Wienert; Jochen Grommes; Houman Jalaie
Journal:  Dtsch Arztebl Int       Date:  2016-12-16       Impact factor: 5.594

2.  Nutcracker syndrome: how are we cracking the nuts and whose nuts are we cracking?

Authors:  Fernando Korkes
Journal:  Int Braz J Urol       Date:  2017 Jul-Aug       Impact factor: 1.541

3.  The Post-thrombotic Syndrome-Prevention and Treatment: VAS-European Independent Foundation in Angiology/Vascular Medicine Position Paper.

Authors:  Benilde Cosmi; Agata Stanek; Matja Kozak; Paul W Wennberg; Raghu Kolluri; Marc Righini; Pavel Poredos; Michael Lichtenberg; Mariella Catalano; Sergio De Marchi; Katalin Farkas; Paolo Gresele; Peter Klein-Wegel; Gianfranco Lessiani; Peter Marschang; Zsolt Pecsvarady; Manlio Prior; Attila Puskas; Andrzej Szuba
Journal:  Front Cardiovasc Med       Date:  2022-02-24

4.  Interventional treatment of postthrombotic syndrome.

Authors:  H Jalaie; K Schleimer; M E Barbati; A Gombert; J Grommes; M A F de Wolf; R de Graaf; C H A Wittens
Journal:  Gefasschirurgie       Date:  2016-07-12

5.  Stent extension into a single inflow vessel is a valuable option after endophlebectomy.

Authors:  Timme Maj van Vuuren; Ralph Lm Kurstjens; Mark Af de Wolf; Jorinde Hh van Laanen; Cees Ha Wittens; Rick de Graaf
Journal:  Phlebology       Date:  2017-11-07       Impact factor: 1.740

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.